Muscle and tendon properties in child cerebral palsy


We are seeking individuals for a study aiming to investigate the mechanical properties of muscles and tendons in the leg. We hope to understand more about how the length and stiffness of muscles change with contracture associated with cerebral palsy, and how that affects the ability to function. Our study uses non-invasive and pain-free techniques to measure musculoskeletal architecture. This includes having an ultrasound scan as well as an MRI scan.

To be considered for this study, participants must be aged between 6 and 16 years, and:

  • have an ankle contracture associated with having cerebral palsy, OR
  • must display typical motor development and be free of lower limb musculoskeletal pathology

Participants will be asked to undergo a single session of testing that will take place at NeuRA. The study lasts for approximately 2 hours. Participants will be reimbursed with movie tickets and have their transportation/parking expenses paid.

If you would like to learn more about this study, please contact Arkiev D’Souza at 02 9399 1832 or

See what’s going on at NeuRA


'I've got the best job for you dad. Your shaky arm will be perfect for it!'

Children… honest and insightful. Their innocence warms the heart. But what words do you use to explain to a child that daddy has an incurable brain disease? What words tell them that in time he may not be able to play football in the park, let alone feed himself? What words help them understand that in the later stages, dementia may also strike? Aged just 36, this was the reality that faced Steve Hartley. Parkinson's disease didn't care he was a fit, healthy, a young dad and devoted husband. It also didn't seem to care his family had no history of it. The key to defeating Parkinson's disease is early intervention, and thanks to a global research team, led by NeuRA, we're pleased to announce that early intervention may be possible. Your support, alongside national and international foundations Shake it Up Australia and the Michael J Fox Foundation, researchers have discovered that a special protein, found in people with a family history of the disease increases prior to Parkinson’s symptoms developing. This is an incredible step forward, because it means that drug therapies, aimed at blocking the increase in the protein, can be administered much earlier – even before symptoms strike. The next step is to understand when to give the drug therapies and which people will most benefit from it. But we need your help. A gift today will support vital research and in time help medical professionals around the world treat Parkinson’s disease sooner, with much better health outcomes. Thank you, in advance, for your support.